Blood Cancer UK

Recent papers from Blood Cancer UK

1. The leukaemia in pregnancy study, a national multicentre retrospective study of pregnancy outcomes in women with concurrent or historic diagnoses of acute leukaemiaBritish Journal of Haematology · 2026
2. RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assemblyLeukemia · 2026
3. SLIT2 modulates leukaemic cell proliferation and stromal support in acute myeloid leukaemia modelsBritish Journal of Haematology · 2026
4. Acute Myeloid Leukaemia Driven by Rare HNRNPH1::ERG Fusion Gene in an Adult, With Distinct Transcripts Detected by RNASeq at Diagnosis and Relapse: A Case ReporteJHaem · 2026
5. Clonal haematopoiesis and outcomes after acute coronary syndrome: a systematic review and meta-analysisESC Heart Failure · 2026
6. Adapting UK Clinical Practise in Chronic Myeloid Leukaemia in Chronic Phase to Contemporary Management Recommendations: The ADAPT 2.0 SurveyEuropean Journal Of Haematology · 2026
7. ID #672 A phase II study of continuous low dose panobinostat in paediatric patients with atypical teratoid rhabdoid tumours (ATRT).Neuro-Oncology Pediatrics · 2026
8. Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression, and blocks myeloid differentiationBlood Neoplasia · 2026
9. Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97)Frontiers in Oncology · 2026
10. Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemiaBritish Journal of Haematology · 2026
11. Development and validation of the INFLammation in Acute Myocardial diseases risk Estimation for Myocardial Infarction (INFLAME-MI) scoreEuropean Journal of Preventive Cardiology · 2026
12. Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaBlood · 2026
13. Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrowENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2026
14. ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemiaCell Reports Medicine · 2026
15. Intronic DNA variants in EZH2 and GATA2 predict treatment-free remission in chronic myeloid leukemia patients from the destiny trialBlood · 2025
16. Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survivalLeukemia · 2025
17. Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cellsDeleted Journal · 2025
18. High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerabilitySignal Transduction and Targeted Therapy · 2025
19. Evaluation of current mouse in vivo models and advanced in vitro models for leukaemia researchENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2025
20. Venetoclax‐based non‐intensive combinations for relapsed/refractory acute myeloid leukaemia—Real‐world data from a UK ‐wide programmeENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2025